NVO Equities

Pharmaceuticals
NHS Prescription Rates for Novo Nordisk's Wegovy Fall Short Amid Clinic Shortages Jul 25, 2024
Stocks
Novo Nordisk Shares Ascend 31% In 2024, Hovering Near Buying Territory Jun 1, 2024
Stocks
Novo Nordisk A/S Announces New Share Repurchase Program Mar 19, 2024
Stocks
Retail Traders Shifting Focus from Tech Giants to Pharma Stocks Mar 9, 2024
Stocks
Novo Nordisk Shares Strategic Progress at Capital Markets Day 2024 Mar 8, 2024
Stocks
Stocks Keeping Pace with Tech Giants—Lower Risk Included Feb 12, 2024
Markets
U.S. Futures Dip As Investors Brace for Economic Indicators Jan 31, 2024
Markets
Stock Market Shows Minute Gains as Tech Giants Amazon and Microsoft Emerge as Front-runners Jan 30, 2024
Markets
Dow Jones Futures Up as Netflix Fuels Tech Sector Optimism, Investor Eyes on Tesla's Earnings Jan 24, 2024
Stocks
Jim Cramer Considers Eli Lilly a Contender for the 'Magnificent Seven' Mega-Caps Jan 23, 2024
Markets
Market Anticipation: A Pre-Jobless Claims Look at Tech Futures Jan 19, 2024
Stocks
Novo Nordisk A/S Reports Share Transactions by Insiders Jan 10, 2024
Companies
The Pursuit of Weight Loss Solutions Spurs Interest in Ozempic Alternatives Dec 4, 2023
Companies
Novo Nordisk Announces a 16 Billion DKK Investment in French Production Site Nov 24, 2023
Stocks
Individual Investors Pile Into Eli Lilly Following Approval of Obesity Drug Nov 18, 2023
Markets
Market Dynamics: Resilience Amidst Uncertainty and Impact on EV Giant Tesla Nov 17, 2023